Department of Cardiology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053, People's Republic of China.
Department of Pharmacy, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053, People's Republic of China.
Drug Des Devel Ther. 2024 Aug 5;18:3461-3476. doi: 10.2147/DDDT.S473251. eCollection 2024.
Cardiovascular diseases (CVDs) tend to affect the young population and are associated with a significant economic burden and psychological distress to the society and families. The physiological and pathological processes underlying CVDs are complex. Ca/calmodulin-dependent kinase II (CaMK II), a protein kinase, has multiple biological functions. It participates in multiple pathological processes and plays a central role in the development of CVDs. Based on this, this paper analyzes the structural characteristics and distribution of CaMK II, the mechanism of action of CaMK II, and the relationship between CaMK II and CVDs, including ion channels, ischemia-reperfusion injury, arrhythmias, myocardial hypertrophy, cardiotoxicity, hypertension, and dilated cardiomyopathy. Given the different regulatory mechanisms of different isoforms of CaMK II, the clinical use of specific targeted inhibitors or novel compounds should be evaluated in future research to provide new directions.
心血管疾病(CVDs)往往影响年轻人群,并给社会和家庭带来巨大的经济负担和心理困扰。CVDs 的生理和病理过程复杂。钙/钙调蛋白依赖性激酶 II(CaMK II)是一种蛋白激酶,具有多种生物学功能。它参与多种病理过程,在 CVDs 的发展中起着核心作用。基于此,本文分析了 CaMK II 的结构特征和分布、作用机制以及与 CVDs 的关系,包括离子通道、缺血再灌注损伤、心律失常、心肌肥厚、心肌毒性、高血压和扩张型心肌病。鉴于不同 CaMK II 同工型的调节机制不同,未来的研究应评估特定靶向抑制剂或新型化合物的临床应用,为治疗 CVDs 提供新的方向。